Category: Drug Side Effects
Invokana Class Action Lawsuit
Update: FDA Requires Boxed Warning on Amputation Risk with Invokana May 16, 2017 – Based on the final results of 2 long-term clinical trials, FDA has concluded that type 2 diabetes patients who take Invokana or Invokamet are twice as...
Victoza Class Action Lawsuit
Update: LEADER Trial Finds Increased Pancreatic Cancer Risk with Victoza June 17, 2016 – A study published this month in the New England Journal of Medicine (NEJM) identified a potential increased risk of pancreatic cancer in type 2 diabetes patients treated...
Uloric Class Action Lawsuit
Uloric (febuxostat) is a drug that prevents flare-ups of gout, a painful medical condition that causes severe arthritis. Although Uloric has only been on the market since 2009, lawsuits have already been filed against its manufacturer, Takeda Pharmaceuticals, for failing...
Pradaxa Class Action Lawsuit
Pradaxa Lawsuits If you were injured by Pradaxa, you are not alone — over 2,000 Pradaxa lawsuits are pending in a federal Multi-District Litigation (MDL). Judge David R. Herndon presides over the litigation in the U.S. District Court for the...
Januvia Class Action Lawsuit
Update: Diabetes Drugs Linked to Rhabdomyolysis December 1, 2017 – Januvia and other diabetes drugs in its class have been associated with a rare, life-threatening muscular disease called rhabdomyolysis, according to the FDA Adverse Event Reporting System (FAERS). Rhabdomyolysis occurs...
Janumet Class Action Lawsuit
Update: FDA to Investigate Janumet / Rhabdomyolysis Link December 1, 2017 – The FDA is considering taking regulatory action over Janumet and other diabetres drugs in its class after finding an increased risk of rhabdomyolysis with the drugs, according to...